Impaired gastric mucosal integrity identified by confocal endomicroscopy in Helicobacter pylori-negative functional

Rui Ji1, Peng Wang1, Guan-Jun Kou1

  • 1Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan, China.

Abstract

Insights

Functional dyspepsia (FD) is linked to impaired gastric barrier function. Increased mast cells in the stomach correlate with this heightened permeability, suggesting a new therapeutic target for FD.

Area of Science:

  • Gastroenterology
  • Pathophysiology
  • Inflammation research

Background:

  • Functional dyspepsia (FD) pathogenesis may involve low-grade inflammation.
  • Altered gastric permeability is hypothesized to contribute to FD onset and persistence.

Purpose of the Study:

  • To evaluate gastric mucosal integrity and mast cell counts in FD patients.
  • To investigate the relationship between gastric permeability and mast cell numbers in FD.

Main Methods:

  • Probe-based confocal endomicroscopy with intravenous fluorescein was used to assess paracellular leakage and cell shedding in 58 FD patients, 20 H. pylori-positive controls, and 20 H. pylori-negative healthy controls.
  • Quantitative immunohistochemistry was employed to identify and quantify mast cells in mucosal biopsies.

Main Results:

  • FD patients exhibited significantly higher paracellular permeability scores compared to healthy controls (P=.006).
  • Mast cell numbers were significantly increased in FD patients versus healthy controls (P<.001).
  • Gastric permeability positively correlated with mast cell numbers in FD patients (rs=.6588, P<.0001).

Conclusions:

  • FD patients demonstrate impaired gastric barrier function.
  • Increased mast cell infiltration and heightened gastric permeability represent a potential pathophysiological mechanism and therapeutic target for FD.

Related Concept Videos

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
502
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.1K
Mucosal Barrier of the Stomach01:25

Mucosal Barrier of the Stomach

The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
2.0K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.0K
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
704
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.1K